Simulation of IGF-I pharmacokinetics after infusion of recombinant IGF-I in human subjects.


Journal Article (Academic article)

The pharmacokinetics of recombinant human insulin-like growth factor I (IGF-I) were studied in four healthy volunteers by a 3-h infusion at a rate of 20 A compartmental model was used to simulate the plasma "free" IGF-I and IGF-I associated with the 50- and 150-kDa plasma protein fractions. The model is based on the concept that free IGF-I and IGF binding proteins (IGFBPs) are the substrates for their own degradation and that they act as reservoirs for retention of IGF-I in the vascular compartment or inhibiting IGF-I action. The metabolic clearance rate (MCR) of free IGF-I is estimated as 2.62 +/- 0.94 ml.min-1.min-1 with a production rate of 4.75 +/- 1.74 mg/day (621.0 +/- 227.34 nmol/day). The simulation shows that higher concentrations of IGFBP-3 would increase the estimate of MCR for free IGF-I by reducing free IGF-I concentration. The model will be of value for simulation of dynamic profiles of free IGF-I and receptor-bound IGF-I in a variety of pathophysiological conditions.

Duke Authors

Cited Authors

  • Boroujerdi, MA; Jones, RH; Sönksen, PH; Russell Jones, DL

Published Date

  • August 1997

Published In

Volume / Issue

  • 273 / 2 Pt 1

Start / End Page

  • E438 - E447

International Standard Serial Number (ISSN)

  • 0002-9513

Conference Location

  • united states